when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Endocrinology & Metabolism · news · pharmadog

← back to Endocrinology & Metabolism

News · Endocrinology & Metabolism

224 stories

25dLabcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseasesfiercebiotech

28dUpdated: FDA adcomm backs popular wellness peptides, despite staff concernsendpoints

28dLilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 databiospace

29dBiopharma layoffs must double in H2 for 2026 to match 2025 cutsbiospace

29dVertex was sole bidder in high-premium Crinetics acquisitionbiopharma dive

29dFDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilotfda press

29dArrowhead hits ‘best-case scenario’ with latest results for fat-lowering drugbiopharma dive

Jul 22, 26From Big Pharma to specialty: why moving closer to the patient changes everythingbiospace

Jul 21, 26‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraisefiercebiotech

Jul 21, 26Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesitybiospace

Jul 21, 26Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone mythstat

Jul 21, 26Agios says adios to sickle cell program over lackluster phase 2 datafiercebiotech

Jul 18, 26Opinion: Beware the unintended consequences of testosterone screening for military servicemembersstat

Jul 18, 26Opinion: STAT readers on the value of primary care, obesity as a disease, and morestat

Jul 17, 26STAT+: The end for GSK’s chronic cough treatmentstat

Jul 17, 26BlossomHill eyes IPO as fertilizer to grow taller in crowded cancer fieldsfiercebiotech

Jul 17, 26STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claimsstat

Jul 17, 26Opinion: MAHA is rewriting the vocabulary of American mental health carestat

Jul 16, 26STAT+: Fresh turmoil roils American Diabetes Association following controversy at conferencestat

Jul 16, 26STAT+: FDA approves Merck’s oral PCSK9 drug, a firststat

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvalsstat

Jul 16, 26STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckleystat

Jul 16, 26STAT+: Amylyx nears pivotal endocrine drug study readoutstat

Jul 15, 26Graham’s death from aortic dissection raises questions about preventing the rare disorderstat

Jul 15, 26Graham’s death from aortic dissection raises questions about preventing the rare disorderstat

Jul 15, 26STAT+: Celcuity’s breast cancer drug approved, its firststat

Jul 15, 26Deaths from coronary artery disease have fallen, but more progress is within reachstat

Jul 15, 26STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expectstat

Jul 14, 26STAT+: Anthropic’s Claude Science is coming for Kendall Squarestat

← prevpage 3 of 8next →